8-K: Cardlytics Achieves Positive Adjusted EBITDA for Full Year 2023, Eyes Double-Digit Billings Growth in 2024

Cardlytics reports its first full year of positive Adjusted EBITDA since 2019, driven by revenue growth and cost structure rebalancing.

Summary

• Cardlytics announced its financial results for the fourth quarter and full year ended December 31, 2023.
• The company achieved its first full year of positive Adjusted EBITDA since 2019, reaching $3.8 million, a significant improvement from a loss of $45.2 million in 2022.
• Fourth-quarter revenue increased by 8.1% year-over-year to $89.2 million, while full-year revenue grew by 3.6% to $309.2 million.
• Billings, a non-GAAP metric, rose by 4.6% in the fourth quarter to $131.9 million and by 2.5% for the full year to $453.4 million.
• The company's net loss attributable to common stockholders significantly decreased to $134.7 million for the full year, compared to a loss of $465.3 million in 2022.
• Cardlytics' MAUs (Monthly Active Users) increased by 7.1% in the fourth quarter to 168 million and by 4.9% for the full year to 162.1 million.
• The company anticipates billings between $105 million and $109 million, revenue between $70 million and $73 million, and adjusted EBITDA between -$1 million and $1 million for the first quarter of 2024.
• Cardlytics expects to achieve double-digit billings growth and positive operating cash flow on an annual basis in 2024.

Sentiment

Score: 8

Explanation: The document conveys a positive sentiment due to the achievement of positive Adjusted EBITDA, reduced net loss, and optimistic future outlook. However, the presence of risks and negative free cash flow prevents a perfect score.

Positives

• The company achieved its first full year of positive Adjusted EBITDA since 2019.
• There was a significant improvement in net loss compared to the previous year.
• Revenue and billings showed growth both in the fourth quarter and for the full year.
• The company's MAUs increased, indicating a growing user base.
• Cardlytics is projecting further growth and positive operating cash flow in 2024.
• Adjusted Contribution increased by 18.2% in Q4 2023 and 10.9% for the full year 2023.

Negatives

• The company still reported a net loss for the full year, although significantly reduced.
• Free cash flow was negative for both the fourth quarter and the full year.
• ARPU (Average Revenue Per User) decreased slightly for the full year, from $1.93 in 2022 to $1.91 in 2023.

Risks

• The company is subject to risks related to unfavorable conditions in the global economy.
• Cardlytics' quarterly operating results have fluctuated and may continue to vary.
• The company is substantially dependent on its platform and key financial institution partners.
• There are risks related to maintaining relationships with key partners and marketers.
• The company's ability to adapt to changing market conditions and consumer habits is crucial.
• The amount and timing of budgets by marketers can affect the company's revenue.

Future Outlook

Cardlytics anticipates double-digit billings growth and positive operating cash flow on an annual basis in 2024. The company also provided guidance for Q1 2024, projecting billings between $105 million and $109 million, revenue between $70 million and $73 million, and adjusted EBITDA between -$1 million and $1 million.

Management Comments

• Karim Temsamani, CEO of Cardlytics, stated that the fourth quarter capped a transformational year for Cardlytics and that the company is now focused on building a best-in-class platform.
• Alexis DeSieno, CFO of Cardlytics, mentioned that achieving growth and improving the capital structure are top priorities and that the company is on a path to double-digit billings growth in 2024 and positive operating cash flow on an annual basis.

Industry Context

The announcement reflects a positive trend in the digital advertising sector, where companies are focusing on profitability and sustainable growth. Cardlytics' focus on leveraging purchase data and partnerships with financial institutions aligns with the industry's move towards targeted and measurable advertising solutions.

Comparison to Industry Standards

• Cardlytics' performance can be compared to other digital advertising platforms such as The Trade Desk (TTD) and PubMatic (PUBM), which also focus on programmatic advertising and data-driven solutions.
• While TTD and PUBM have demonstrated higher revenue growth rates in recent periods, Cardlytics' achievement of positive Adjusted EBITDA is a significant milestone, indicating improved financial health.
• Cardlytics' reliance on financial institution partnerships is a unique aspect of its business model, differentiating it from other ad tech companies that primarily rely on direct relationships with publishers and advertisers.
• The company's MAU growth of 7.1% in Q4 is a positive sign, but it is important to compare this to the user growth rates of other platforms to assess its competitive position.
• Cardlytics' ARPU of $1.91 for the full year is relatively low compared to some other ad tech companies, suggesting potential for further monetization of its user base.

Stakeholder Impact

• Shareholders will likely view the positive Adjusted EBITDA and reduced net loss favorably.
• Employees may be encouraged by the company's improved financial health and growth prospects.
• Customers and partners may benefit from the company's focus on platform improvements and better outcomes.
• Suppliers and creditors may have increased confidence in the company's ability to meet its obligations.

Next Steps

• Cardlytics will continue to focus on building a best-in-class platform with top-tier targeting and a differentiated user experience.
• The company will work towards achieving double-digit billings growth and positive operating cash flow in 2024.
• Cardlytics will continue to monitor and adapt to changing market conditions and consumer habits.

Key Dates

Keywords

Cardlytics, digital advertising, financial results, Adjusted EBITDA, billings, revenue, MAUs, ARPU, net loss, operating cash flow